Insights

Acquisition Activity The recent acquisition of LumiraDx's point-of-care platform by Roche indicates a strong industry shift toward integrated diagnostics solutions, presenting opportunities to approach healthcare providers and labs using LumiraDx’s technology for upgrades or complementary products.

Market Expansion LumiraDx’s innovation and recent sales of technology assets to Roche suggest potential for expanding into new markets such as chronic disease management and personalized diagnostics, targeting healthcare systems seeking advanced point-of-care testing capabilities.

Technological Focus LumiraDx’s cutting-edge diagnostic platform, now part of Roche, represents a prime opportunity to target clinics and hospitals that prioritize next-generation, rapid testing solutions to improve patient outcomes and operational efficiency.

Financial Growth With annual revenues estimated between $25 million and $50 million, there is significant growth potential for sales professionals to engage with comparable-sized companies in the healthcare diagnostics space seeking innovative solutions to scale their offerings.

Partnership Opportunities The recent appointment of senior technical personnel and collaborations in the diagnostics field indicate an active market for partnerships, licensing, and joint ventures that can facilitate faster adoption of advanced testing platforms across diverse healthcare settings.

LumiraDx Tech Stack

LumiraDx uses 8 technology products and services including Power BI, Cloudflare, Microsoft SharePoint, and more. Explore LumiraDx's tech stack below.

  • Power BI
    Business Intelligence
  • Cloudflare
    Content Management System
  • Microsoft SharePoint
    Content Management System
  • SAP
    Customer Relationship Management
  • NetSuite
    E-commerce
  • Microsoft Excel
    Editors
  • Wistia
    Online Video Platforms
  • Microsoft Azure
    Platform As A Service

Media & News

LumiraDx's Email Address Formats

LumiraDx uses at least 1 format(s):
LumiraDx Email FormatsExamplePercentage
First.Last@lumiradx.comJohn.Doe@lumiradx.com
98%
First.Middle@lumiradx.comJohn.Michael@lumiradx.com
1%
First@lumiradx.comJohn@lumiradx.com
1%

Frequently Asked Questions

Where is LumiraDx's headquarters located?

Minus sign iconPlus sign icon
LumiraDx's main headquarters is located at 3 More London Riverside London, England se1 2aq United Kingdom. The company has employees across 5 continents, including EuropeNorth AmericaSouth America.

What is LumiraDx's stock symbol?

Minus sign iconPlus sign icon
LumiraDx is a publicly traded company; the company's stock symbol is LMDX.

What is LumiraDx's official website and social media links?

Minus sign iconPlus sign icon
LumiraDx's official website is lumiradx.com and has social profiles on LinkedInCrunchbase.

What is LumiraDx's NAICS code?

Minus sign iconPlus sign icon
LumiraDx's NAICS code is 62 - Health Care and Social Assistance.

How many employees does LumiraDx have currently?

Minus sign iconPlus sign icon
As of May 2026, LumiraDx has approximately 328 employees across 5 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Risk Officer (technical): N. M.Chief Technology Officer: D. S.Chief Scientist: J. M.. Explore LumiraDx's employee directory with LeadIQ.

What industry does LumiraDx belong to?

Minus sign iconPlus sign icon
LumiraDx operates in the Hospitals and Health Care industry.

What technology does LumiraDx use?

Minus sign iconPlus sign icon
LumiraDx's tech stack includes Power BICloudflareMicrosoft SharePointSAPNetSuiteMicrosoft ExcelWistiaMicrosoft Azure.

What is LumiraDx's email format?

Minus sign iconPlus sign icon
LumiraDx's email format typically follows the pattern of First.Last@lumiradx.com. Find more LumiraDx email formats with LeadIQ.

When was LumiraDx founded?

Minus sign iconPlus sign icon
LumiraDx was founded in 2014.

LumiraDx

Hospitals and Health CareEngland, United Kingdom201-500 Employees

Roche Diagnostics has acquired LumiraDx's next-generation point-of-care Platform technology. This is a significant milestone, and we are excited about the next chapter, combining our knowledge and expertise to continue delivering innovative solutions for patients.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Section iconCompany Overview

Headquarters
3 More London Riverside London, England se1 2aq United Kingdom
Stock Symbol
LMDX
NAICS Code
62 - Health Care and Social Assistance
Founded
2014
Employees
201-500

Section iconFunding & Financials

  • $25M$50M

    LumiraDx's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    LumiraDx's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.